WebJan 15, 2007 · Cisplatin NS 0.05 - 1 mg/mL 250 - 500 mL 1-2 hours Hydration; Do not refrigerate; Cladrabine NS 500 - 1000 mL 2 hours, CIVI Usually given as 7 day CIVI … WebCisplatin is approved to be used alone or with other drugs to treat: Bladder cancer. It is used alone in patients with advanced cancer that cannot be treated with other therapies, such as surgery or radiation therapy. Ovarian cancer that has spread to other parts of the body. It is used with other drugs in patients who have already had surgery ...
Cisplatin (Platinol®) OncoLink
WebMay 8, 2024 · Blood and Urine Collection Success and Analyte Measurements Obtained at the Earlier Cisplatin Visits (EV) and Later Cisplatin Visits (LV) eTable 3. Description of Data Collection Success Rate and Missing Data Rate eTable 4. Correlation Between Serum Laboratory Values Measured By Routine Care and Study-Specific Values eTable 5. WebMay 1, 2024 · Assessments occurred at early (first or second cycle) and late (last or second to last cycle) cisplatin infusions. Results: The most common diagnoses were central nervous system tumors (58 [36%]), neuroblastoma (43 [27%]), … data structures and algorithms c
National Center for Biotechnology Information
WebCisplatin is known to have an additive or synergistic effect in combination with gemcitabine in a number of different tumor types (e.g., lung, 9 bladder, 10 and head and neck 11 cancers). We ... WebFeb 16, 2024 · Cisplatin dosing information Usual Adult Dose for Testicular Cancer: 20 mg/m2 by slow IV infusion daily for 5 days per cycle in combination with other approved … WebFeb 16, 2016 · Nephrotoxicity during CCRT (Glomerular Filtration Rate [GFR] <50 mL/min) may require cisplatin dose reductions. This in turn, however, may lead to poorer treatment outcomes. ... Evaluation of renal function took place the day before every cisplatin infusion, 4 consecutive weeks after the last infusion, 3 months after the final infusion … bitterne preschool